Substantial Weight Reduction In a 48-week Phase 2 obesity trial, participants receiving retatrutide 12 mg once weekly reached an average 24.2% body weight reduction , with weight loss continuing through the study period rather than plateauing early
Which should you choose
Gastrointestinal symptomsparticularly nausea, vomiting, diarrhoea, and constipationare the most frequently reported adverse effects of GLP-1 receptor agonists, occurring in 2050% of patients depending on the specific agent and dose according to clinical trials and SmPC data
We have taken this time to review our weight management programs and have made changes in regards to our pricing structures with weight loss consultations, follow ups and variations on purchases
We observed no evidence of dominance effects ( P = 0.80), indicating that the allelic dosage of the T allele contributes to efficacy in an additive manner
We dont think compounded drugs are inherently bad